• Himanshu Goyal, Binit Sureka, Nachiketa Mangaraj, Ashish Agarwal, Nikhil Kothari, M K Garg, Mithu Banerjee, Ashwini Agarwal, Pawan Garg, Taruna Yadav, and Pushpinder Khera.
• Department of Diagnostic & Interventional Radiology, All India Institute of Medical Sciences - Jodhpur, India.
• Afr Health Sci. 2023 Dec 1; 23 (4): 647464-74.

Background16-66% of COVID-19 positive patients may have abdominal symptoms and findings in abdominal CT. The yield of abdominal CT scan in patients having abdominal complaints is not known.ObjectivesThe aim of this study was to explore the various abdominal imaging manifestations of COVID-19 and COVID-19 associated Mucormycosis (CAM) and to identify the relevant clinical and laboratory features associated with severity of the symptoms.MethodsA retrospective single centre observational study was performed at a tertiary care hospital in Northwest India. All consecutive patients who had COVID positive RT-PCR report and had undergone abdominal Computed Tomography scan from March 2020 to November 2021 for various abdominal complaints were included. Demographic data, CT images and reports and all relevant lab parameters were collected.ResultsOut of 75 patients, positive abdominal findings were seen in 65 patients. Hepatobiliary findings were seen in 41.3% (31 of 75; OR=1.9) and bowel abnormalities were found in 37.3% (28 of 75; OR=2.1) of COVID-19 patients. 7 patients who had renal infarcts or bowel ischemia were found to have COVID-19 associated Mucormycosis on histopathology.ConclusionChest CT severity score was positively correlated with most of the abdominal manifestations in patients requiring ICU admission. Elevated D-dimer levels were significantly associated with abdominal symptoms.© 2023 Himanshu G et al.

27 keywords...

hide…